Arkolith/Insider Trading/INBS/Form 4

Sakiris Spiro Kevin

Chief Financial OfficerINTELLIGENT BIO SOLUTIONS INC. (INBS) · full profile →Form 4 · filed Jul 11, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 10, 2023Conversion(C)2K$5.80$14K5K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 10, 2023Conversion(C)16K—$00

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-23-024239) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML